spot_img

Inotiv, Inc. to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results and Host Conference Call on Wednesday, December 3, 2025

WEST LAFAYETTE, Ind., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization...

Actimed Therapeutics Announces Important Licensing Agreement with Mankind Pharma

Covers exclusive rights to S-pindolol, the novel therapy in development for the treatment of cachexia, in India and South AsiaRepresents a major step in...

Top Stories

admin

LuckyWins Unveils Risk-Free Welcome Credit for New Players

Canberra, Australia , Nov. 20, 2025 (GLOBE NEWSWIRE) -- LuckyWins, a leading online casino in Australia, is happy to announce the launch of its risk-free welcome credit for new players. Designed to empower new players to comfortably browse and practise the platform’s extensive catalogue of table...
admin

Revology Cars Redefines a Legend with 1969 Boss 429 World Debut...

LOS ANGELES, Nov. 21, 2025 /PRNewswire/ -- Revology Cars, the world's leading builder of re-engineered and restored 1960s Mustangs, has unveiled its most sophisticated Mustang yet: the 1969 Boss 429. Revology 1969 Mustang Boss 429 Designed,...

Most Popular

People

Munro Supply Celebrates 60 Years of Service in the Rocky Mountain...

admin
People

Men’s Health Awareness Month: Concussion Experts Urge Men to Recognize Depression...

admin
People

LuckyWins Unveils Risk-Free Welcome Credit for New Players

admin
People

Camp Social Announces Official Launch of New Website

admin
People

Religious and Spiritual Products Market Growth Trends, Competitive Strategies and Forecasts...

admin
admin

Henlius’ Serplulimab (anti-PD-1 mAb) Granted Breakthrough Therapy Designation by China NMPA...

The first CDE-designated Breakthrough Therapy for perioperative gastric cancer, promising accelerated patient access. The world's first gastric cancer perioperative regimen replacing chemotherapy with immunotherapy alone in the adjuvant setting has met primary endpoints in its phase 3 clinical trial, significantly reducing recurrence risk and...
admin

Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for...

Renowned urologist Dr. Mark Hong sets new global benchmark for urologist-led, MRI-guided prostate treatment, leading a growing movement toward incision-free prostate therapyTORONTO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered,...
spot_img

Category

From Italy to the Philippines: Candy Introduces a New Era of...

admin

CAMP4 Announces Pricing of Initial Public Offering

admin